Gamma-Tocotrienol Inhibits ErbB3-dependent PI3K/Akt Mitogenic Signalling in Neoplastic Mammary Epithelial Cells

Overview

Journal Cell Prolif

Date 2006 Nov 18

PMID 17109639

Citations 40

Authors

G V Samant

P W Sylvester

Affiliations

Soon will be listed here.

Abstract

The antiproliferative effects of gamma-tocotrienol are associated with suppression in epidermal growth factor (EGF)-dependent phosphatidylinositol-3-kinase (PI3K)/PI3K-dependent kinase-1 (PDK-1)/Akt mitogenic signalling in neoplastic mammary epithelial cells. Studies were conducted to investigate the direct effects of gamma-tocotrienol treatment on specific components within the PI3K/PDK-1/Akt mitogenic pathway. +SA cells were grown in culture and maintained in serum-free media containing 10 ng/ml EGF as a mitogen. Treatment with 0-8 microm gamma-tocotrienol resulted in a dose-responsive decrease in the +SA cell growth and a corresponding decrease in phospho-Akt (active) levels. However, gamma-tocotrienol treatment had no direct inhibitory effect on Akt or PI3K enzymatic activity, suggesting that the inhibitory effects of gamma-tocotrienol occur upstream of PI3K, possibly at the level of the EGF-receptor (ErbB1). Additional studies were conducted to determine the effects of gamma-tocotrienol on ErbB receptor activation. Results showed that gamma-tocotrienol treatment had little or no effect on ErbB1 or ErbB2 receptor tyrosine phosphorylation, a prerequisite for substrate interaction and signal transduction, but did cause a significant and progressive decrease in the ErbB3 tyrosine phosphorylation. Because ErbB1 or ErbB2 receptors form heterodimers with the ErbB3 receptor, and ErbB3 heterodimers have been shown to be the most potent activators of PI3K, these findings strongly suggest that the antiproliferative effects of gamma-tocotrienol in neoplastic +SA mouse mammary epithelial cells are mediated by a suppression in ErbB3-receptor tyrosine phosphorylation and subsequent reduction in PI3K/PDK-1/Akt mitogenic signalling.

Citing Articles

Gamma-tocotrienol Inhibits Proliferation and Growth of HSD17B4 Overexpressing HepG2 Liver Cancer Cells.

Wang X, Liang X, Zhang N, Wang Y, Hu M, Shi Y Curr Cancer Drug Targets. 2024; 25(2):170-182.

PMID: 38934283 DOI: 10.2174/0115680096319171240623091614.

Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action.

Talib W, Ahmed JumAH D, Attallah Z, Jallad M, Al Kury L, Hadi R Front Nutr. 2024; 10:1281879.

PMID: 38274206 PMC: 10808607. DOI: 10.3389/fnut.2023.1281879.

Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity.

Vo H, Nguyen Y, Kim N, Lee H Int J Mol Sci. 2023; 24(23).

PMID: 38069361 PMC: 10707015. DOI: 10.3390/ijms242317038.

Revisiting the therapeutic potential of tocotrienol.

Ranasinghe R, Mathai M, Zulli A Biofactors. 2022; 48(4):813-856.

PMID: 35719120 PMC: 9544065. DOI: 10.1002/biof.1873.

Consumption of Supplementary Inulin Modulates Milk Microbiota and Metabolites in Dairy Cows with Subclinical Mastitis.

Wang Y, Nan X, Zhao Y, Jiang L, Wang H, Zhang F Appl Environ Microbiol. 2021; 88(4):e0205921.

PMID: 34936838 PMC: 8942464. DOI: 10.1128/AEM.02059-21.

References

Olayioye M, Neve R, Lane H, Hynes N . The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000; 19(13):3159-67. PMC: 313958. DOI: 10.1093/emboj/19.13.3159. View

Danielson K, Anderson L, Hosick H . Selection and characterization in culture of mammary tumor cells with distinctive growth properties in vivo. Cancer Res. 1980; 40(6):1812-9. View

Sylvester P, Birkenfeld H, Hosick H, Briski K . Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro. Exp Cell Res. 1994; 214(1):145-53. DOI: 10.1006/excr.1994.1243. View

Bazley L, Gullick W . The epidermal growth factor receptor family. Endocr Relat Cancer. 2005; 12 Suppl 1:S17-27. DOI: 10.1677/erc.1.01032. View

Downward J . Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 1998; 10(2):262-7. DOI: 10.1016/s0955-0674(98)80149-x. View

Shah S, Sylvester P . Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood). 2005; 230(4):235-41. DOI: 10.1177/153537020523000402. View

Prigent S, Gullick W . Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 1994; 13(12):2831-41. PMC: 395164. DOI: 10.1002/j.1460-2075.1994.tb06577.x. View

Toker A . Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol Pharmacol. 2000; 57(4):652-8. View

Karunagaran D, Tzahar E, Beerli R, Chen X, Ratzkin B, Seger R . ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 1996; 15(2):254-64. PMC: 449940. View

10.

Fedi P, PIERCE J, Di Fiore P, Kraus M . Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol Cell Biol. 1994; 14(1):492-500. PMC: 358399. DOI: 10.1128/mcb.14.1.492-500.1994. View

11.

Britten C . Targeting ErbB receptor signaling: a pan-ErbB approach to cancer. Mol Cancer Ther. 2004; 3(10):1335-42. View

12.

McIntyre B, Briski K, Gapor A, Sylvester P . Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med. 2000; 224(4):292-301. DOI: 10.1046/j.1525-1373.2000.22434.x. View

13.

Normanno N, Campiglio M, De L, Somenzi G, Maiello M, Ciardiello F . Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. Ann Oncol. 2002; 13(1):65-72. DOI: 10.1093/annonc/mdf020. View

14.

Shah S, Gapor A, Sylvester P . Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer. 2003; 45(2):236-46. DOI: 10.1207/S15327914NC4502_14. View

15.

Sylvester P, Nachnani A, Shah S, Briski K . Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr. 2002; 11 Suppl 7:S452-9. DOI: 10.1046/j.1440-6047.11.s.7.9.x. View

16.

Sliwkowski M, Schaefer G, Akita R, Lofgren J, FITZPATRICK V, Nuijens A . Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem. 1994; 269(20):14661-5. View

17.

Shah S, Sylvester P . Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem Cell Biol. 2005; 83(1):86-95. DOI: 10.1139/o04-127. View

18.

Anderson L, Danielson K, Hosick H . Metastatic potential of hyperplastic alveolar nodule derived mouse mammary tumor cells following intravenous inoculation. Eur J Cancer Clin Oncol. 1981; 17(9):1001-8. DOI: 10.1016/s0277-5379(81)80005-3. View

19.

Holbro T, Beerli R, Maurer F, Koziczak M, Barbas 3rd C, Hynes N . The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A. 2003; 100(15):8933-8. PMC: 166416. DOI: 10.1073/pnas.1537685100. View

20.

Yarden Y . The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001; 37 Suppl 4:S3-8. DOI: 10.1016/s0959-8049(01)00230-1. View